文献速递糖尿病

团队协作、目标设定、技术与严密控制:新诊断1型糖尿病试点4T研究

Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Type 1 Diabetes: the Pilot 4T Study.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

该试点研究在斯坦福儿童健康中心招募135名新诊断1型糖尿病青少年,比较4T队列与历史队列的HbA1c结局。4T队列在诊断后6、9、12个月的HbA1c均低于历史队列,且接受远程监测者HbA1c更低,多变量回归显示4T队列4至12个月HbA1c上升幅度显著更低(P < .001)。

要点

  • 4T队列诊断后6、9、12个月HbA1c较历史队列降低0.54%至0.52%及0.58%。
  • 4T队列内接受远程监测者6、9、12个月HbA1c较未接受者降低0.14%、0.18%至0.14%。
  • 4T队列4至12个月HbA1c上升幅度显著低于历史队列(P < .001)。

核心结论

  • 以技术为支持、基于团队的新发强化教育(包括目标设定、CGM启动和远程数据回顾)在诊断后12个月显著降低1型糖尿病青少年的HbA1c。

研究设计与样本

  • 试点4T研究,在斯坦福儿童健康中心招募135名新诊断1型糖尿病青少年,将4T队列与历史队列的HbA1c进行比较。
  • 自2018年7月起,所有诊断1型糖尿病1个月内的青少年均被提供CGM启动,2019年3月增加远程CGM数据回顾。
  • 采用局部估计散点图平滑(LOESS)估计队列间HbA1c差异;采用分段混合效应回归模型估计从最低点HbA1c(第4个月)至诊断后12个月的变化,并校正诊断年龄、性别、种族和保险类型。

主要发现

  • 4T队列诊断后6、9、12个月HbA1c较历史队列分别降低0.54%至0.52%及0.58%。
  • 4T队列内,接受远程监测者诊断后6、9、12个月HbA1c较未接受者分别降低0.14%、0.18%至0.14%。
  • 多变量回归分析显示,4T队列在第4至12个月期间HbA1c上升幅度显著更低(P < .001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Youth with type 1 diabetes (T1D) do not meet glycated hemoglobin A1c (HbA1c) targets. OBJECTIVE: This work aimed to assess HbA1c outcomes in children with new-onset T1D enrolled in the Teamwork, Targets, Technology and Tight Control (4T) Study. METHODS: HbA1c levels were compared between the 4T and historical cohorts. HbA1c differences between cohorts were estimated using locally estimated scatter plot smoothing (LOESS). The change from nadir HbA1c (month 4) to 12 months post diagnosis was estimated by cohort using a piecewise mixed-effects regression model accounting for age at diagnosis, sex, ethnicity, and insurance type. We recruited 135 youth with newly diagnosed T1D at Stanford Children's Health. Starting July 2018, all youth within the first month of T1D diagnosis were offered continuous glucose monitoring (CGM) initiation and remote CGM data review was added in March 2019. The main outcomes measure was HbA1c. RESULTS: HbA1c at 6, 9, and 12 months post diagnosis was lower in the 4T cohort than in the historic cohort (-0.54% to -0.52%, and -0.58%, respectively). Within the 4T cohort, HbA1c at 6, 9, and 12 months post diagnosis was lower in those patients with remote monitoring than those without (-0.14%, -0.18% to -0.14%, respectively). Multivariable regression analysis showed that the 4T cohort experienced a significantly lower increase in HbA1c between months 4 and 12 (P < .001). CONCLUSION: A technology-enabled, team-based approach to intensified new-onset education involving target setting, CGM initiation, and remote data review statistically significantly decreased HbA1c in youth with T1D 12 months post diagnosis.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Prahalad P, Ding VY, Zaharieva DP, et al. Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Type 1 Diabetes: the Pilot 4T Study. J Clin Endocrinol Metab. 2022. PMID: 34850024. doi:10.1210/clinem/dgab859

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。